Progression of Amyloid Pathology to Alzheimer's Disease Pathology in an Amyloid Precursor Protein Transgenic Mouse Model by Removal of Nitric Oxide Synthase 2
Donna M. Wilcock(Institute for Neurodegenerative Disorders), Carol A. Colton(Duke Medical Center)
Cited by 194
Related Papers
Heterogeneity of Microglial Activation in the Innate Immune Response in the Brain
|Journal of Neuroimmune Pharmacology|2009|872
Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition
|Journal of Neuroinflammation|2020|144
Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies
|Alzheimer s Research & Therapy|2011|135